Clinical trial
Satisfaction and Quality of Life in Patients With a Diagnosis of Non Valvular Atrial Fibrillation Who Take Rivaroxaban for Stroke Prevention
NCT01805531 is registered in ClinicalTrials.gov with Bayer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Satisfaction and Quality of Life in Patients With a Diagnosis of Non Valvular Atrial Fibrillation Who Take Rivaroxaban for Stroke Prevention
- Lead sponsor
- Bayer
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 30, 2013
- Completion date
- March 31, 2015
- Enrollment
- 411 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.